Trials / Unknown
UnknownNCT00736320
HD16 for Early Stage Hodgkin Lymphoma
HD16 for Early Stages - Treatment Optimization Trial in the First-line Treatment of Early Stage Hodgkin Lymphoma; Treatment Stratification by Means of FDG-PET
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1,150 (actual)
- Sponsor
- University of Cologne · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed to test the non-inferiority of the experimental arm compared to the standard arm in terms of Progression free survival (PFS).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ABVD (Adriamycin, Bleomycin, Vincristine, Dacarbazine) | chemotherapy with 2 cycles of ABVD (day 1 + 15) |
| RADIATION | 20 Gy IFRT (Involved Field Radiotherapy) | 20 Gy Involved Field Radiotherapy |
Timeline
- Start date
- 2009-11-01
- Primary completion
- 2018-09-01
- Completion
- 2021-12-01
- First posted
- 2008-08-15
- Last updated
- 2020-11-04
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00736320. Inclusion in this directory is not an endorsement.